Jun 22, 2020
InventHelp Inventor Develops Human Brain Model for Psychiatrists (PND-5039)
Jun 18, 2020
Scientists Decode How the Brain Senses Smell
May 05, 2020
Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers
Apr 17, 2020
Arlo Announces Initiative To Help Provide Meals For Communities Sheltering At Home Through Second Harvest Food Bank Donations
Apr 15, 2020
ICBII Announces the Approval of its latest patent on Blood-Brain Barrier Permeable Technology accelerating the company's progress towards treating Neuro-Degenerative Alzheimer's and Parkinson's Diseases.
Apr 07, 2020
Brain Simulator II Enables Evolution of Artificial Intelligence
Apr 06, 2020
Allen Institute Announces New Phase Of Neuroscience Research
Feb 11, 2020
US Nuclear Joins the Brain-Machine Interface Revolution
Feb 06, 2020
AFTD Welcomes Rosa Canet-Avilés, Ph.D., as Senior Director of Scientific Initiatives
Jan 13, 2020
For the Littlest Patients, Neuro Evaluation Just Got Better: Pediatric Whole-Brain Myelin Volume Quantification Now Clinical Routine
Dec 12, 2019
Brain Monitoring Market Report 2019-2024 - Global Market Set to Reach $11.6B by 2024, but Hindered by the Shortage of Trained Professionals & Unfavorable Reimbursement Policies
Dec 10, 2019
MAZON Outraged That Congress Yet Again Ignores The Needs Of Hungry Military Families By Not Including The Military Family Basic Needs Allowance Provision In The FY2020 NDAA Bill
Dec 03, 2019
OpenTable Partners with No Kid Hungry to Help End Child Hunger During the Holidays
Dec 03, 2019
Concussion Alters How Information Is Transmitted Within the Brain
Dec 03, 2019
Focused Ultrasound May Open Door to Alzheimer's Treatment
Nov 20, 2019
Center on Addiction Raises Over $2 Million at 2019 Gala
Nov 18, 2019
Alkermes to Acquire Rodin Therapeutics
Oct 30, 2019
A New High-Resolution Map of How the Brain is Wired
Oct 24, 2019
Fourth Annual AFTD Benefit Raises More Than $2 Million in Support of Frontotemporal Degeneration Research, Support and Awareness
Oct 21, 2019
Amygdala Neurosciences Awarded $1.35 million NIH Grant to Conduct Long Term, Phase 3 Enabling, Toxicology Studies